Literature DB >> 9409739

Purification and microsequencing of hyaluronidase isozymes from human urine.

A B Csóka1, G I Frost, T Wong, R Stern, T B Csóka.   

Abstract

We recently cloned the major hyaluronidase of human plasma, which we termed HYAL1. All hyaluronidase activity could be purified from human urine on an anti-HYAL1 monoclonal antibody column. However, urine contains two hyaluronidases of 57 kDa and 45 kDa, whereas plasma only contains the 57 kDa activity. Microsequencing confirmed that both urinary isozymes have N-termini identical to plasma hyaluronidase, but a second N-terminus was found in the smaller isozyme, apparently derived from the terminal 25 amino acids of HYAL1, at the C-terminus. The two polypeptides of the 45 kDa isozyme resulting from endoproteolytic cleavage of the 57 kDa isoform are presumably linked by disulfide bonds. Sperm contains two isozymes of the testicular hyaluronidase, PH-20, and the lower molecular weight isozyme is believed to be an endoproteolytically processed form of the larger protein. Analogously to PH-20, the smaller isozyme of HYAL1 is likely to be a proteolytically processed product of the larger isozyme.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409739     DOI: 10.1016/s0014-5793(97)01309-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome.

Authors:  Leslie B Gordon; Ingrid A Harten; Anthony Calabro; Geetha Sugumaran; Antonei B Csoka; W Ted Brown; Vincent Hascall; Bryan P Toole
Journal:  Hum Genet       Date:  2003-05-01       Impact factor: 4.132

Review 2.  Hyaluronidases: their genomics, structures, and mechanisms of action.

Authors:  Robert Stern; Mark J Jedrzejas
Journal:  Chem Rev       Date:  2006-03       Impact factor: 60.622

Review 3.  Immunologic roles of hyaluronan.

Authors:  Mark E Mummert
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX.

Authors:  B Triggs-Raine; T J Salo; H Zhang; B A Wicklow; M R Natowicz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Hyaluronan digestion controls DC migration from the skin.

Authors:  Jun Muto; Yasuhide Morioka; Kenshi Yamasaki; Margaret Kim; Andrea Garcia; Aaron F Carlin; Ajit Varki; Richard L Gallo
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

6.  Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling.

Authors:  Caitlin O McAtee; Christine Booth; Christian Elowsky; Lei Zhao; Jeremy Payne; Teresa Fangman; Steve Caplan; Michael D Henry; Melanie A Simpson
Journal:  Matrix Biol       Date:  2018-05-10       Impact factor: 11.583

7.  Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces.

Authors:  Martin Falkowski; Kai Schledzewski; Berit Hansen; Sergij Goerdt
Journal:  Histochem Cell Biol       Date:  2003-11-04       Impact factor: 4.304

Review 8.  Hyalurondiase: both a tumor promoter and suppressor.

Authors:  Vinata B Lokeshwar; Marie G Selzer
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 9.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

10.  Designed human serum hyaluronidase 1 variant, HYAL1DeltaL, exhibits activity up to pH 5.9.

Authors:  Stephan Reitinger; Johannes Müllegger; Brigitte Greiderer; Jens Erik Nielsen; Günter Lepperdinger
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.